Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study.
Galuba V, Cordes J, Feyerabend S, Riesbeck M, Meisenzahl-Lechner E, Correll CU, Kluge M, Neff A, Zink M, Langguth B, Reske D, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Leucht S, Schmidt-Kraepelin C; COMBINE Study Group.
Galuba V, et al. Among authors: zink m.
Schizophr Res. 2024 Aug;270:383-391. doi: 10.1016/j.schres.2024.06.033. Epub 2024 Jul 9.
Schizophr Res. 2024.
PMID: 38986385
Free article.
Clinical Trial.